Currently out of the existing stock ratings of Zhiqiang Shu, 26 are a BUY (89.66%), 3 are a HOLD (10.34%).
Analyst Zhiqiang Shu, has had 32.69% of price targets met with an average potential upside of 15.97%, reached in 43 days on average. Previously, Zhiqiang Shu worked at BERENBERG.
Zhiqiang Shu has documented 56 price targets and ratings displayed on 13 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 13-Sep-2023.
Analyst best performing recommendations are on BNTX (BIONTECH SE).
The best stock recommendation documented was for BNTX (BIONTECH SE) on 8/2/2021. The price target of $400 was fulfilled within 2 days with a profit of $64.24 (19.13%), with a performance score of 95.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Aug-2024
$8
$40
1 years 7 months 17 days ago
(31-Mar-2025)
9/14 (64.29%)
$3.12 (63.93%)
186
Hold Since 08-Nov-2021
$5
$40
1 years 8 months 24 days ago
(24-Feb-2025)
1/6 (16.67%)
$0.95 (23.46%)
36
Sell Since 24-Feb-2025
$6.2
1 years 8 months 24 days ago
(24-Feb-2025)
1/2 (50%)
$-0.22 (-3.43%)
4
Hold Since 29-Mar-2021
$8
1 years 10 months 10 days ago
(07-Jan-2025)
2/11 (18.18%)
$-1.02 (-11.31%)
20
Buy Since 07-Nov-2023
$6
1 years 11 months 1 days ago
(16-Dec-2024)
2/4 (50%)
$-3.89 (-39.33%)
70